DOI : 10.1055/s-00000059

Pneumologie

Issue S 01 · Volume 73 · March 2019 DOI: 10.1055/s-009-42542


60. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.
München, 13.–16.03.2019

Kongresspräsident: Prof. Dr. med. Jürgen Behr, München
Abstracts (HTML) List of Authors
P240
Zangrilli, JG; Wenzel, S; Brusselle, G; Hirsch, I; Rastogi, S: Benralizumab Efficacy in Patients with Uncontrolled Eosinophilic Asthma by Age at Diagnosis
P243
Bardsley, G; Daley-Yates, P; Baines, A; Riddell, K; Joshi, S; Bareille, P; Beasley, R; Fingleton, J: The duration of anti-inflammatory action of fluticasone furoate (FF) assessed via exhaled nitric oxide (FeNO) in asthmatics following administration of FF/vilanterol (VI)
P244
Trudo, F; Kreindler, J; Lugogo, N; Martin, U; Cook, B; Hirsch, I: Peripheral Blood Eosinophil Shifts in Severe, Uncontrolled Asthma
P245
Trudo, F; Bleeker, ER; FitzGerald, JM; Barker, P; Werkstrom, V; Rastogi, S; Martin, U: Patients Remaining Exacerbation-Free During Benralizumab Treatment Compared With Placebo: Analysis of Pooled Data From the SIROCCO and CALIMA Trials
P246
Trudo, F; Hirsch, I; Martin, U: Impact of Body Mass Index on Efficacy of Benralizumab in Patients with Severe, Uncontrolled Eosinophilic Asthma: Pooled Analysis of the SIROCCO and CALIMA Trials
P250
Zangrilli, JG; Chipps, BE; Hirsch, I; Trudo, F; Alacqua, M: Demographics, Clinical Characteristics, and Response to Benralizumab Treatment for Patients with Severe, Eosinophilic Asthma and Fixed Airflow Obstruction
P574
Scuri, M; Singh, D; Fabbri, LM; Guasconi, A; Vezzoli, S; Prunier, H; Muraro, A; Petruzzelli, S; Papi, A: Single Inhaler Extrafine Triple Therapy Improves Clinical Outcomes in Gold B COPD Patients: Post-Hoc Analysis of the TRIBUTE study
P581
Andreas, S; Bothner, U; de la Hoz, A; Kloer, I; Trampisch, M; Alter, P: Holter ECG-based arrhythmia and heart rate analysis in patients with COPD receiving a fixed-dose combination of tiotropium/olodaterol versus its monocomponents
P669
Fabbri, LM; Singh, D; Roche, N; Corradi, M; Guasconi, A; Scuri, M; Montagna, I; Cohuet, G; Francisco, C; Vezzoli, S; Petruzzelli, S; Papi, A: Reduction in fatal events with extrafine inhaled corticosteroid (ICS)-containing medications: Results of stratified safety pooled analysis of the TRILOGY, TRINITY and TRIBUTE studies
P674
Fabbri, LM; Singh, D; Valente, I; Guasconi, A; Prunier, H; Georges, G; Papi, A: Extrafine single inhaler triple therapy improves quality of life in COPD. Analysis of SGRQ subdomains of the TRIBUTE study
P751
Buscham, H; Schlesinger, A; Thomas, J; Balboni, C: Das Palliativnotbett −3-Jahres-Ergebnisse eines Modellversuchs in Köln
P528
Fricke, R; Weltz, C; Schmidt, B: Chancen und Perspektiven multiprofessioneller Palliativdienste in der Pneumologie
P520
Berghof, K; Auer, M; Behr, J; Huber, RM; Syunyaeva, Z; Tufman, A: Luftnot und Lebensqualität bei stationären Patienten mit Lungenerkrankungen: eine multifaktorielle Analyse
P504
Elmas, H; Wagner, P; Rabe, KF; Welker, L: Differenzialdiagnostik benigner Pleuraergüsse
P345
Darlington, P; Zenner, M; Schwaderer, P; Hartmut, W; Hetzel, M: Sicherheit und diagnostische Wertigkeit der CT-gesteuerten Biopsie zur Abklärung von Herdbefunden der Lunge
P103
Hauber, HP; Reitz, F; Müller-Ehmsen, J: Einfluss von Vorhofflimmern auf Morbidität und Mortalität bei COPD